Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT
· Real-Time Price · USD
7.68
-0.99 (-11.42%)
At close: Aug 15, 2025, 3:59 PM
7.83
1.95%
After-hours: Aug 15, 2025, 07:47 PM EDT
Sagimet Biosciences Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q1 2022 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Mar 31, 2022 | Mar 31, 2021 |
Cash & Equivalents | 42.33M | 64.72M | 75.84M | 77.01M | 95.96M | 176.78M | 75.14M | 101.84M | 18.51M | 12.34M | 158K | -56.73M | 74.94M |
Short-Term Investments | 83.08M | 79.85M | 75.41M | 75.47M | 70.41M | 16.93M | 19.76M | n/a | n/a | 12.92M | 32.19M | 113.46M | n/a |
Long-Term Investments | 10.06M | n/a | 7.41M | 17.47M | 22.12M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | 62K | 306K | n/a | n/a | n/a | n/a | n/a | n/a | 27K | 27K | -56.73M | 27K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 1.79M | 888K | 463K | 407K | 130K | 108K | 397K | 77K | 2.74M | 1.42M | 34K | n/a | 37K |
Total Current Assets | 127.2M | 146.07M | 152.77M | 157.19M | 166.75M | 194.49M | 96.65M | 102.82M | 21.35M | 27.05M | 32.79M | 56.73M | 77.01M |
Property-Plant & Equipment | 152K | 38K | 77K | 114K | 151K | 37K | 73K | 109K | 144K | 178K | 212K | n/a | 161K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 10.21M | 100K | 7.79M | 17.59M | 22.27M | 37K | 73K | 109K | 144K | 205K | 239K | -56.73M | 188K |
Total Assets | 137.41M | 146.17M | 160.26M | 174.78M | 189.02M | 194.53M | 96.72M | 102.92M | 21.5M | 27.25M | 33.03M | n/a | 77.2M |
Account Payables | 1.92M | 3.22M | 1.43M | 1.15M | 1.99M | 531K | 186K | 1.7M | 2.72M | 1.46M | 1.13M | n/a | 1.86M |
Deferred Revenue | n/a | n/a | n/a | n/a | -153K | n/a | n/a | 3.15M | 2.32M | 3.52M | 3.96M | n/a | 767K |
Short-Term Debt | 152K | n/a | n/a | n/a | 153K | 26K | 65K | 103K | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 4.31M | 16K | 5K | 11K | 10K | 3.61M | 168K | -3.16M | 411K | 1.03M | 57K | n/a | 1.05M |
Total Current Liabilities | 7.25M | 7.18M | 4.45M | 4.09M | 5.73M | 4.51M | 5.65M | 5.05M | 5.29M | 5.29M | 5.28M | n/a | 3.13M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1K | 214.63M | 214.63M | 214.62M | n/a | 214.63M |
Total Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | 3.95M | n/a | 1K | 214.63M | 214.66M | 214.7M | n/a | 214.66M |
Total Liabilities | 7.25M | 7.18M | 4.45M | 4.09M | 5.73M | 4.51M | 5.65M | 5.05M | 219.91M | 219.95M | 219.98M | n/a | 217.78M |
Total Debt | 152K | 39K | 78K | 116K | 153K | 26K | 65K | 103K | 140K | 176K | 211K | n/a | 176K |
Common Stock | 3K | 3K | 3K | 3K | 3K | 3K | 2K | 2K | 1K | 1K | 1K | n/a | 1K |
Retained Earnings | -323.87M | -313.49M | -295.31M | -279.11M | -264.49M | -256.37M | -249.74M | -241.59M | -235.24M | -228.46M | -221.87M | n/a | -172.47M |
Comprehensive Income | 76K | 121K | 230K | 441K | -23K | 7K | 30K | n/a | -214.63M | -13K | -84K | -158.26M | -214.62M |
Shareholders Equity | 130.16M | 138.99M | 155.81M | 170.68M | 183.29M | 190.02M | 91.06M | 97.88M | -198.41M | -192.7M | -186.95M | 56.37M | -140.58M |
Total Investments | 93.14M | 79.85M | 82.82M | 92.94M | 92.53M | 16.93M | 19.76M | n/a | n/a | 12.92M | 32.19M | 113.46M | n/a |